These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18544305)

  • 1. Management of anticoagulation and platelet inhibition in reconstructive vascular surgery.
    Comerota AJ; Thakur S
    Vascular; 2008; 16 Suppl 1():S48-54. PubMed ID: 18544305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peripheral arterial revascularization: which antithrombotic agents?].
    Haulon S; Susen S; Koussa M; Jude B
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1278-84. PubMed ID: 11794970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins.
    Dagher NN; Modrall JG
    Semin Vasc Surg; 2007 Mar; 20(1):10-4. PubMed ID: 17386359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of surgical patients receiving anticoagulation and antiplatelet agents.
    Thachil J; Gatt A; Martlew V
    Br J Surg; 2008 Dec; 95(12):1437-48. PubMed ID: 18991253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Low molecular weight heparin in patients undergoing vascular surgery].
    Godet G; Kretz JG; Cristea T
    Ann Fr Anesth Reanim; 2005 Apr; 24(4):347-54. PubMed ID: 15826784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative anticoagulation in vascular surgery: part 1. A retrospective comparison of clinical outcomes for unfractionated heparin versus low-molecular-weight heparin.
    Gramse CA; Hingorani A; Ascher E
    J Vasc Nurs; 2001 Jun; 19(2):42-9; quiz 50-1. PubMed ID: 11395717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailored antithrombotic therapy for acute coronary syndromes.
    Fitchett D
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):935-44. PubMed ID: 18666844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes related to antiplatelet or anticoagulation use in patients undergoing carotid endarterectomy.
    Rosenbaum A; Rizvi AZ; Alden PB; Tretinyak AS; Graber JN; Goldman JA; Sullivan TM
    Ann Vasc Surg; 2011 Jan; 25(1):25-31. PubMed ID: 20889291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: a proposed algorithm based on individual risk stratification.
    Patti G; Di Sciascio G
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):128-34. PubMed ID: 19670304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy for vascular interventions.
    Comerota AJ; Thakur S
    Perspect Vasc Surg Endovasc Ther; 2008 Mar; 20(1):28-35. PubMed ID: 18388025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of anticoagulation therapy for invasive procedures.
    Gaines KK
    Urol Nurs; 2005 Oct; 25(5):379-80. PubMed ID: 16294616
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
    Helft G; Gilard M; Le Feuvre C; Zaman AG
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.
    Spyropoulos AC; Douketis JD
    Int Angiol; 2008 Aug; 27(4):333-43. PubMed ID: 18677297
    [No Abstract]   [Full Text] [Related]  

  • 15. Perioperative management of long-term anticoagulation.
    Kearon C
    Semin Thromb Hemost; 1998; 24 Suppl 1():77-83. PubMed ID: 9840696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Longterm treatment of POAD with anticoagulants and platelet inhibitors after endovascular procedures and vascular surgery: what is evidence based?].
    Landgraf H
    Hamostaseologie; 2006 Aug; 26(3):239-44; quiz 245-6. PubMed ID: 16906242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative.
    Wang TY; Chen AY; Peterson ED; Becker RC; Gibler WB; Ohman EM; Roe MT
    Eur Heart J; 2008 May; 29(9):1103-9. PubMed ID: 18353757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of bleeding in patients using antithrombotic agents: prediction, prevention, protection and problem-oriented intervention.
    Scharf RE
    Hamostaseologie; 2009 Nov; 29(4):388-98. PubMed ID: 19882082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices.
    Faxon DP
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S3-14. PubMed ID: 17710074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.